Pro Research: Wall Street takes on Eli Lilly's prospects

Wall Street eyes CRISPR Therapeutics’ growth By Investing.com – Canada Boosts

© Reuters. Discover Wall Road’s professional insights with this ProResearch article, which is able to completely be accessible to InvestingPro subscribers quickly. Improve your funding technique with ProPicks, our latest product that includes methods which have outperformed the S&P 500 by as much as 700%. This Cyber Monday, take pleasure in as much as 60%…

Read More
AbbVie enters agreement to acquire Cerevel Therapeutics

AbbVie enters agreement to acquire Cerevel Therapeutics By Investing.com – Canada Boosts

© Reuters AbbVie (ABBV) enters settlement to accumulate Cerevel Therapeutics (CERE) AbbVie Inc . (NYSE:) introduced Wednesday, alongside Cerevel Therapeutics Holdings Inc (NASDAQ:), that the 2 have entered right into a definitive settlement for AbbVie to accumulate Cerevel, in addition to its strong neuroscience pipeline of a number of clinical-stage and preclinical candidates. The acquisition…

Read More
Roche to acquire obesity drug maker Carmot Therapeutics for $2.7 billion

Roche to acquire obesity drug maker Carmot Therapeutics for $2.7 billion By Reuters – Canada Boosts

© Reuters. FILE PHOTO: The brand of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Picture ZURICH (Reuters) -Pharmaceutical big Roche mentioned on Monday it has entered right into a definitive settlement to amass Carmot Therapeutics, a U.S. firm with a analysis deal with weight problems, for…

Read More
Consilium sees 35% revenue surge, aims for $1.4 billion by 2026

Addex Therapeutics outlines Q3 2023 results and upcoming developments By Investing.com – Canada Boosts

© Reuters. Addex Therapeutics, throughout its Q3 2023 earnings name, supplied updates on its monetary outcomes and progress in numerous drug growth applications. The corporate highlighted achievements such because the completion of recruitment for a Part 2 epilepsy research by accomplice Janssen, and progress in its collaboration with Indivior on substance use dysfunction remedies. Addex…

Read More